The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 104.00
Bid: 102.00
Ask: 106.00
Change: -1.50 (-1.42%)
Spread: 4.00 (3.922%)
Open: 105.50
High: 105.50
Low: 104.00
Prev. Close: 105.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CLN Conversion to Equity

5 Jan 2021 11:00

RNS Number : 5946K
Intercede Group PLC
05 January 2021
 

 

 

5 January 2021

 

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

 

CLN Conversion to Equity

 

Intercede, the leading specialist in digital identities, credential management and secure mobility, announces the conversion by Harwood Capital Nominees of £100,000 nominal of the convertible loan note instrument dated 28 December 2016 (the "CLN"). The conversion into 145,322 ordinary shares of 1 pence each in the Company ("Ordinary Shares") was at the fixed conversion price of 68.8125 pence per Ordinary Share. Following this conversion, £4,905,000 remains outstanding under the CLN.

 

Issue of Equity

 

Application has been made for 145,322 new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on or around 8 January 2021. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares.

 

Following the issue of the new Ordinary Shares, the total number of shares in issue is 50,669,248 Ordinary Shares, each with voting rights. The Company holds 41,645 Ordinary Shares in treasury, therefore the total number of voting rights in the Company is 50,627,603.

 

The figure of 50,627,603 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

ENQUIRIES

 

Intercede Group plc  Tel. +44 (0)1455 558 111Klaas van der Leest, Chief Executive

Andrew Walker, Finance Director

 

finnCap Tel. +44 (0)20 7220 0500Stuart Andrews, Corporate Finance

Simon Hicks, Corporate Finance

 

About Intercede

 

Intercede is a cybersecurity company specialising in digital identities, credential management and secure mobility.

 

Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

 

Our vision is to make the highest levels of cybersecurity available to all organisations, solving complexity issues by simplifying the management of digital credentials, securely and at scale.

 

We have been delivering trusted solutions to high profile customers for over 20 years. Our team of experts has deployed millions of identities to governments, most of the largest aerospace and defence corporations, and major financial services and healthcare organizations, as well as leading telecommunications, cloud services and information technology firms, providing industry-leading employee and customer credential management systems.

 

For more information visit: www.intercede.com

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESSDFSIEFSEIF
Date   Source Headline
18th Jul 20177:00 amRNSDirector/PDMR Shareholding & TVR
13th Jun 20177:00 amRNSCollaborations with VMWare and Imagination
7th Jun 201712:06 pmRNSHolding(s) in Company
7th Jun 201712:01 pmRNSHolding(s) in Company
7th Jun 20177:00 amRNSFinal Results
6th Jun 20177:00 amRNSLaunch of MyIDaaS
25th May 20177:00 amRNSSchedule 2(g) Disclosure
23rd May 20177:00 amRNSAppointment of Chief Sales Officer
17th May 20177:00 amRNSNon-Executive Director Appointment
9th May 20177:00 amRNSContract Win
8th May 20173:45 pmRNSShare Incentive Plan
8th May 20177:00 amRNSIntercede announces Secure Login for WordPress
5th Apr 20177:00 amRNSTrading Update
31st Mar 20177:00 amRNSListing of Convertible Loan Notes
20th Mar 20177:00 amRNSAppointment of VP, US Gov't & Enterprise Sales
15th Mar 20173:03 pmRNSShare Incentive Plan
9th Mar 20177:00 amRNSAppointment of Adviser
3rd Mar 20177:00 amRNSTrading Update
27th Jan 201712:15 pmRNSResult of General Meeting
5th Jan 20177:00 amRNSReceipt of $3.0m Order
28th Dec 20167:00 amRNSProposed Fundraising
28th Dec 20167:00 amRNSDirectorate Change
28th Dec 20167:00 amRNSHalf-year Report
16th Sep 20162:15 pmRNSDirector/PDMR Shareholding
16th Sep 20167:00 amRNSTrading Update
14th Sep 20163:52 pmRNSResult of AGM
1st Aug 20167:00 amRNSIssue of Equity & Share Incentive Plan
7th Jun 20167:00 amRNSFinal Results
18th May 20167:00 amRNSShare Incentive Plan
7th Apr 20167:00 amRNSYear End Trading Update
21st Mar 20161:21 pmRNSShare Incentive Plan
1st Mar 20162:00 pmRNSMyID within Intel Authenticate
22nd Feb 20167:00 amRNSNew Android Security Platform
7th Jan 20163:28 pmRNSTransaction in Own Shares
3rd Nov 20157:00 amRNSHalf Yearly Report
7th Oct 20157:00 amRNSTrading Update
16th Sep 20154:40 pmRNSResult of AGM
2nd Sep 20152:53 pmRNSShare Award
30th Jul 20153:37 pmRNSShare Incentive Plan
6th Jul 20157:00 amRNSTrading Update
2nd Jun 20157:00 amRNSFinal Results
28th May 20157:00 amRNSIntercede & Good to deliver secure mobility
19th May 20157:00 amRNSNew Partner for Intercede's MyTAM Service
14th May 20157:00 amRNSShare Incentive Plan
13th May 20157:00 amRNSIntercede & Citrix to deliver secure mobility
21st Apr 20157:00 amRNSNew Partner for Intercede's MyTAM Service
2nd Apr 201512:00 pmRNSTrading Update
18th Mar 20157:00 amRNSShare Incentive Plan
16th Mar 20157:00 amRNSAppointment of Non-Executive Director
26th Feb 20157:01 amRNSNew Partner for Intercede's MyTAM Service

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.